In this issue of Child and Adolescent Psychiatric Clinics, guest editors Drs. Jeffrey H. Newcorn and Timothy E. Wilens bring their considerable expertise to the topic of Updates in Pharmacologic Strategies in ADHD. Top experts in the field cover key topics such as PK of stimulants pharmacogenomics, stimulants, nonstimulants, neurotherapeutics, and more.
Contains 15 relevant, practice-oriented topics including special groups: ADHD+, such as mood/ dysregulation and disruptive behavior; SUD; autism; tics, Tourette syndrome, and anxiety; sleep; cardiovascular; college-aged; transitional-aged youth; adults; and more
Provides in-depth clinical reviews on pharmacologic strategies in ADHD, offering actionable insights for clinical practice
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xii 7. Preface - p. xiii 8. From Structural Disparities to Neuropharmacology: A Review of Adult Attention-Deficit/Hyperactivity Disorder Medication Treatment - p. 343 9. Measurement Informed Care in Attention-Deficit/Hyperactivity Disorder (ADHD) - p. 363 10. Stimulants - p. 373 11. The Pharmacokinetics and Pharmacogenomics of Psychostimulants - p. 393 12. Nonstimulant Treatments for ADHD - p. 417 13. Cardiovascular Considerations for Stimulant Class Medications - p. 437 14. Pharmacotherapy of Attention-Deficit/Hyperactivity Disorder in Individuals with Autism Spectrum Disorder - p. 449 15. Pharmacologic Treatment of Comorbid Attention-Deficit/Hyperactivity Disorder and Tourette and Tic Disorders - p. 469 16. Updates in Pharmacologic Strategies for Emotional Dysregulation in Attention Deficit Hyperactivity Disorder - p. 479 17. Attention Deficit Hyperactivity Disorder Medications and Sleep - p. 499 18. ADHD and Substance Use Disorders in Young People: Considerations for Evaluation, Diagnosis, and Pharmacotherapy - p. 515 19. Addressing the Treatment and Service Needs of Young Adults with Attention Deficit Hyperactivity Disorder - p. 531 20. Updates in Pharmacologic Strategies in Adult Attention-Deficit/Hyperactivity Disorder - p. 553 21. A Review of Clinical Practice Guidelines in the Diagnosis and Treatment of Attention-Deficit/Hyperactivity Disorder - p. 569
In this issue of Child and Adolescent Psychiatric Clinics, guest editors Drs. Jeffrey H. Newcorn and Timothy E. Wilens bring their considerable expertise to the topic of Updates in Pharmacologic Strategies in ADHD. Top experts in the field cover key topics such as PK of stimulants pharmacogenomics, stimulants, nonstimulants, neurotherapeutics, and more.
Contains 15 relevant, practice-oriented topics including special groups: ADHD+, such as mood/ dysregulation and disruptive behavior; SUD; autism; tics, Tourette syndrome, and anxiety; sleep; cardiovascular; college-aged; transitional-aged youth; adults; and more
Provides in-depth clinical reviews on pharmacologic strategies in ADHD, offering actionable insights for clinical practice
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xii 7. Preface - p. xiii 8. From Structural Disparities to Neuropharmacology: A Review of Adult Attention-Deficit/Hyperactivity Disorder Medication Treatment - p. 343 9. Measurement Informed Care in Attention-Deficit/Hyperactivity Disorder (ADHD) - p. 363 10. Stimulants - p. 373 11. The Pharmacokinetics and Pharmacogenomics of Psychostimulants - p. 393 12. Nonstimulant Treatments for ADHD - p. 417 13. Cardiovascular Considerations for Stimulant Class Medications - p. 437 14. Pharmacotherapy of Attention-Deficit/Hyperactivity Disorder in Individuals with Autism Spectrum Disorder - p. 449 15. Pharmacologic Treatment of Comorbid Attention-Deficit/Hyperactivity Disorder and Tourette and Tic Disorders - p. 469 16. Updates in Pharmacologic Strategies for Emotional Dysregulation in Attention Deficit Hyperactivity Disorder - p. 479 17. Attention Deficit Hyperactivity Disorder Medications and Sleep - p. 499 18. ADHD and Substance Use Disorders in Young People: Considerations for Evaluation, Diagnosis, and Pharmacotherapy - p. 515 19. Addressing the Treatment and Service Needs of Young Adults with Attention Deficit Hyperactivity Disorder - p. 531 20. Updates in Pharmacologic Strategies in Adult Attention-Deficit/Hyperactivity Disorder - p. 553 21. A Review of Clinical Practice Guidelines in the Diagnosis and Treatment of Attention-Deficit/Hyperactivity Disorder - p. 569
